Report on Global and Chinese IVD Industry
INTRODUCTION
Two thirds of medical treatment decisions in the global was made based on assay results, however, spending on assays only makes up 1% of total medical expenditures. To improve the technology, methods and spending on assays would contribute to disease prevention, diagnosis and treatment. It demonstrates commercial opportunities as well.
The major market demand of IVD comes from developed countries such as North America, Europe, Japan, etc., nonetheless, developing countries such as China, India and Brazil has shown increasing demand in recent years. So far, there are around 400 IVD companies in China, with the top 20 occupying 30% of the market share. The market size of IVD in China was about RMB15 billion in 2013, which will grow to RMB30 million in 2018.
In this report, ASKCI analyzes IVD in China to provide understanding of this industry in terms of market demand, key players, regulations, etc. Meanwhile, recommendations will be given at the end of the report to describe the prospect and provide forward-thinking strategies.
1) The Aim of Report
The report will investigate global and Chinese IVD industry from the following aspects:
Two thirds of medical treatment decisions in the global was made based on assay results, however, spending on assays only makes up 1% of total medical expenditures. To improve the technology, methods and spending on assays would contribute to disease prevention, diagnosis and treatment. It demonstrates commercial opportunities as well.
The major market demand of IVD comes from developed countries such as North America, Europe, Japan, etc., nonetheless, developing countries such as China, India and Brazil has shown increasing demand in recent years. So far, there are around 400 IVD companies in China, with the top 20 occupying 30% of the market share. The market size of IVD in China was about RMB15 billion in 2013, which will grow to RMB30 million in 2018.
In this report, ASKCI analyzes IVD in China to provide understanding of this industry in terms of market demand, key players, regulations, etc. Meanwhile, recommendations will be given at the end of the report to describe the prospect and provide forward-thinking strategies.
1) The Aim of Report
- To provide readers with comprehensive and in-depth understanding of Chinese IVD industry;
- To analyze market size of the global and China to indicate market potential;
- To disclose market segments and application;
- To discuss influence of governmental regulation on the industry;
- To analyze drivers and barriers of the industry;
- To reveal opportunities for IVD in China.
- Obtain latest information of IVD industry, such as demand, market segment, regulation, etc.in the globe and China;
- Discover market opportunities in different segments;
- Find out how Chinese IVD market will change and how your business can be involved in;
- Keep informed of your competitors/their activities in China;
- Learn about key market drivers and barriers;
- Share this information within your organization using free global intranet license.
The report will investigate global and Chinese IVD industry from the following aspects:
- Global and Chinese market overview;
- Market demand in different segments;
- Regulation and policy;
- Key players;
- Prospect;
- Commercial opportunity.
EXECUTIVE SUMMARY
DEFINITION AND METHODOLOGY
I OVERVIEW OF IVD IN THE GLOBE
I-1 General Introduction
I-2 Market Size
I-3 Market Segment
II OVERVIEW OF IVD IN CHINA
II-1 General Introduction
II-2 Market Size
II-3 Market Segment
II-4 Industrial Chain
II-5 Regulation and Policy
III ANALYSIS OF GLOBAL IVD BY MARKET SEGMENT
III-1 Point-of-care Tests
III-2 Core Laboratory Tests
III-3 Molecular Assays
III-4 Hematology
III-5 Coagulation
III-6 Microbiology
III-7 Tests Used in Blood Banking
III-8 Histology and Cytology
IV ANALYSIS OF CHINESE IVD BY MARKET SEGMENT
IV-1 Molecular Assays
IV-1.1 Overview
IV-1.2 Market Size
IV-1.3 Application
IV-2 Immunoassays
IV-3 Biochemical Assays
IV-4 Blood and Humoral Assays
IV-5 Microbiological Assays
V KEY PLAYERS OF IVD IN THE GLOBE
V-1 Abbott Laboratories
V-2 Becton, Dickinson & Co.
V-3 Danaher Corp.
V-4 Johnson & Johnson
V-5 Roche
V-6 Siemens
VI KEY PLAYERS OF IVD IN CHINA
VI-1 Key Players for Molecular Assays
VI-1.1 Daan Gene
VI-1.1.1 Company Introduction
VI-1.1.2 Product Category
VI-1.1.3 Operation Analysis
VI-1.2 Kehua Bio-engineering
VI-1.3 ZJ Bio-Tech
VI-1.4 Fosun Pharma
VI-2 Key Players for Immunoassays
VI-2.1 Wantai BioPharm
VI-2.2 InTec
VI-2.3 Rongsheng Biotech
VI-3 Key Players for Clinical Biochemical Assays
VI-3.1 Leadman
VI-3.2 Beijing Strong Biotechnologies
VII PROSPECT OF IVD IN CHINA
VIII CONCLUSION AND RECOMMENDATIONS
ASKCI'S LEGAL DISCLAIMER
LIST OF TABLE
Table I-2-1 Global IVD sales by region, 2013-2018
Table VI-1.1.2-1 Product range of Daan Gene
Table VI-1.1.3-1 Operation Analysis of Daan Gene
LIST OF FIGURE
Figure I-3-1 Market share of Global IVD by segment
Figure II-2-1 Market size of IVD in China, 2008-2013
Figure II-3-1 Market share of Chinese IVD by segment
DEFINITION AND METHODOLOGY
I OVERVIEW OF IVD IN THE GLOBE
I-1 General Introduction
I-2 Market Size
I-3 Market Segment
II OVERVIEW OF IVD IN CHINA
II-1 General Introduction
II-2 Market Size
II-3 Market Segment
II-4 Industrial Chain
II-5 Regulation and Policy
III ANALYSIS OF GLOBAL IVD BY MARKET SEGMENT
III-1 Point-of-care Tests
III-2 Core Laboratory Tests
III-3 Molecular Assays
III-4 Hematology
III-5 Coagulation
III-6 Microbiology
III-7 Tests Used in Blood Banking
III-8 Histology and Cytology
IV ANALYSIS OF CHINESE IVD BY MARKET SEGMENT
IV-1 Molecular Assays
IV-1.1 Overview
IV-1.2 Market Size
IV-1.3 Application
IV-2 Immunoassays
IV-3 Biochemical Assays
IV-4 Blood and Humoral Assays
IV-5 Microbiological Assays
V KEY PLAYERS OF IVD IN THE GLOBE
V-1 Abbott Laboratories
V-2 Becton, Dickinson & Co.
V-3 Danaher Corp.
V-4 Johnson & Johnson
V-5 Roche
V-6 Siemens
VI KEY PLAYERS OF IVD IN CHINA
VI-1 Key Players for Molecular Assays
VI-1.1 Daan Gene
VI-1.1.1 Company Introduction
VI-1.1.2 Product Category
VI-1.1.3 Operation Analysis
VI-1.2 Kehua Bio-engineering
VI-1.3 ZJ Bio-Tech
VI-1.4 Fosun Pharma
VI-2 Key Players for Immunoassays
VI-2.1 Wantai BioPharm
VI-2.2 InTec
VI-2.3 Rongsheng Biotech
VI-3 Key Players for Clinical Biochemical Assays
VI-3.1 Leadman
VI-3.2 Beijing Strong Biotechnologies
VII PROSPECT OF IVD IN CHINA
VIII CONCLUSION AND RECOMMENDATIONS
ASKCI'S LEGAL DISCLAIMER
LIST OF TABLE
Table I-2-1 Global IVD sales by region, 2013-2018
Table VI-1.1.2-1 Product range of Daan Gene
Table VI-1.1.3-1 Operation Analysis of Daan Gene
LIST OF FIGURE
Figure I-3-1 Market share of Global IVD by segment
Figure II-2-1 Market size of IVD in China, 2008-2013
Figure II-3-1 Market share of Chinese IVD by segment
